Lysine acetyltransferase 6A (KAT6A) is a chromatin modulator associated with a rare genetic NDD characterized by brain, cardiac, and ocular abnormalities, along with growth retardation and ID (Urreizti et al., 2020; Jiang et al., 2021). The gene discussed is KAT6A; the disease is Neurodevelopmental delay.